Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04FFM
|
|||
| Former ID |
DNCL002609
|
|||
| Drug Name |
ADXS-HPV
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Cervical cancer [ICD-11: 2C77.0] | Phase 2 | [1] | |
| Cervical Intraepithelial neoplasia [ICD-11: 2E66.1; ICD-10: N87.2] | Phase 2 | [1] | ||
| Company |
Advaxis
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Human papillomavirus protein E7 (HPV E7) | Target Info | . | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02002182) Window of Opportunity Trial of ADXS 11-001 Vaccination Prior to Robotic Surgery of HPV-Positive Oropharyngeal Cancer. U.S. National Institutes of Health. | |||
| REF 2 | ADXS11-001 immunotherapy targeting HPV-E7: updated survival and safety data from a phase 2 study in Indian women with recurrent/refractory cervical cancer. Journal for ImmunoTherapy of Cancer, 2013, 1(Suppl 1):P231. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.